The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory

Vaccines based on mRNA-containing lipid nanoparticles (LNPs) are a promising new platform used by two leading vaccines against COVID-19. Clinical trials and ongoing vaccinations present with varying degrees of protection levels and side effects. However, the drivers of the reported side effects rema...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	iScience Jg. 24; H. 12; S. 103479
Hauptverfasser:	Ndeupen, Sonia, Qin, Zhen, Jacobsen, Sonya, Bouteau, Aurélie, Estanbouli, Henri, Igyártó, Botond Z.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Elsevier Inc 17.12.2021 Elsevier
Schlagworte:	Biological sciences Biotechnology Immunology Biotechnology Biological sciences Immunology
ISSN:	2589-0042, 2589-0042
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!